Abstract:ABSTRACT Gut dysbiosis is closely related to dysregulated microRNAs (miRNAs) in the intestinal epithelial cells, which plays an important role in the pathogenesis of Crohn’s disease (CD). We investigated the relationship between fecal gut microbiome (GM) and intestinal tissue miRNAs in different stages of pediatric CD. Metagenomic analysis and miRNA sequencing were conducted to examine the GM and intestinal miRNA profiles of CD patients before and after clinical induction therapy and the controls. Twenty-seven newly diagnosed, therapy-naïve pediatric patients with active CD and 11 non-inflammatory bowel disease (IBD) controls were recruited in this study. Among CD patients, 11 patients completed induction treatment and reached clinical remission. Both GM and miRNA profiles were significantly changed between CD patients and controls. Seven key bacteria were identified at species level including Defluviitalea raffinosedens , Thermotalea metallivorans , Roseburia intestinalis , Dorea sp. AGR2135, Escherichia coli , Shigella sonnei , and Salmonella enterica , the exact proportions of which were further validated by real-time quantitative PCR analysis. Eight key miRNAs were also identified including hsa-miR-215-5p, hsa-miR-194-5p, hsa-miR-12135, hsa-miR-509-3-5p, hsa-miR-212-5p, hsa-miR-4448, hsa-miR-501-3p, and hsa-miR-503-5p. The functional enrichment analysis of differential miRNAs indicated the significantly altered cyclin protein, cyclin-dependent protein, and cell cycle pathway. The close interactions between seven key bacteria and eight key miRNAs were further investigated by miRNA target prediction. The association between specific miRNA expressions and key gut bacteria at different stages of CD supported their important roles as potential molecular biomarkers. Understanding the relationship between them will help us to explore the molecular mechanisms of CD. IMPORTANCE Since previous studies have focused on the change of the fecal gut microbiome and intestinal tissue miRNA in pediatric Crohn’s disease (CD), the relationship between them in different stages is still not clear. This is the first study to explore the gut microbiota and miRNA and their correlations with the Pediatric Crohn’s Disease Activity Index (PCDAI). Crohn’s Disease Endoscopic Index of Severity (CDEIS), and calprotectin, by applying two omics approach in three different groups (active CD, CD in remission with exclusive enteral nutrition or infliximab induction therapy, and the healthy controls). Both gut microbiome structure and the miRNA profiles were significantly changed in the different stage of CD. Seven key gut microbiome at species and eight key miRNAs were found, and their close interactions were further fully investigated by miRNA target prediction.

Two Distinct Metacommunities Characterize the Gut Microbiota in Crohn'S Disease Patients

Integrative Multi-Omics Deciphers the Spatial Characteristics of Host-Gut Microbiota Interactions in Crohn’s Disease

P1241 Distinct gut microbiota in Crohn's Disease between inflammatory B1 and stricturing B2 phenotype

Potential contributions of keystone species to intestinal ecosystem in patients with Crohn's disease

Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease

Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease

Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

Bacterial microbiome profiles of the inflamed terminal ileum mucosa in active Crohn’s disease patients

Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn’s disease

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.

Integration of Taxa Abundance and Occurrence Frequency to Identify Key Gut Bacteria Correlated to Clinics in Crohn's Disease.

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model

Characterization of Fungal and Bacterial Dysbiosis in Young Adult Chinese Patients with Crohn's Disease.

Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease

Fecal Fungal Microbiota Alterations Associated with Clinical Phenotypes in Crohn's Disease in Southwest China.

Manipulation of Gut Microbiota as a Key Target for Crohn's Disease

Targeted Metagenome Based Analyses Show Gut Microbial Diversity of Inflammatory Bowel Disease patients

Enhanced Microbiota Profiling in Patients with Quiescent Crohn's Disease Through Comparison with Paired Healthy First-Degree Relatives.